TD Waterhouse Canada »

Enlivex Therapeutics shares owned by TD Waterhouse Canada

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by TD Waterhouse Canada from 13F filings

Historical chart of TD Waterhouse Canada investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by TD Waterhouse Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by TD Waterhouse Canada

Quarter filed Position value Share count Share price at filing
2026-03-31 $144 150 0.96